Precision Therapy in RAS Mutant Colorectal Cancer
Gespeichert in:
| Veröffentlicht in: | Gastroenterology (New York, N.Y. 1943) N.Y. 1943), 2020-03, Vol.158 (4), p.806-811 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 811 |
|---|---|
| container_issue | 4 |
| container_start_page | 806 |
| container_title | Gastroenterology (New York, N.Y. 1943) |
| container_volume | 158 |
| creator | Dienstmann, Rodrigo Connor, Kate Byrne, Annette T. Fridman, W.H. Lambrechts, D. Sadanandam, A. Trusolino, L. Prehn, J.H.M. Tabernero, J. Kolch, W. |
| description | |
| doi_str_mv | 10.1053/j.gastro.2019.12.051 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2344275908</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0016508520301141</els_id><sourcerecordid>2344275908</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-6380d66bdf994be1729a9c53e59f3c56ea949e6fe43766f399b1c6f9447835003</originalsourceid><addsrcrecordid>eNp9kEtLw0AUhQdRbK3-A5Es3STOO5mNIMUXVBSt62EyudEpaabOJEL_vSmpLl2dzXfu4X4InROcESzY1Sr7MLELPqOYqIzQDAtygKZE0CLFmNBDNB1CpgIXYoJOYlxhjBUryDGaMKJySlk-ReQlgHXR-TZZfkIwm23i2uT15i156jvTdsncN35AOtMkc9NaCKfoqDZNhLN9ztD73e1y_pAunu8f5zeL1HJcdKlkBa6kLKtaKV4CyakyygoGQtXMCglGcQWyBs5yKWumVEmsrBXnecEExmyGLse7m-C_eoidXrtooWlMC76PmjLOaS4ULgaUj6gNPsYAtd4EtzZhqwnWO1l6pUdZeidLE6oHWUPtYr_Ql2uo_kq_dgbgegRg-PPbQdDROhgkVG6nRFfe_b_wA5T7epA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2344275908</pqid></control><display><type>article</type><title>Precision Therapy in RAS Mutant Colorectal Cancer</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>Alma/SFX Local Collection</source><creator>Dienstmann, Rodrigo ; Connor, Kate ; Byrne, Annette T. ; Fridman, W.H. ; Lambrechts, D. ; Sadanandam, A. ; Trusolino, L. ; Prehn, J.H.M. ; Tabernero, J. ; Kolch, W.</creator><creatorcontrib>Dienstmann, Rodrigo ; Connor, Kate ; Byrne, Annette T. ; Fridman, W.H. ; Lambrechts, D. ; Sadanandam, A. ; Trusolino, L. ; Prehn, J.H.M. ; Tabernero, J. ; Kolch, W. ; COLOSSUS Consortium</creatorcontrib><identifier>ISSN: 0016-5085</identifier><identifier>EISSN: 1528-0012</identifier><identifier>DOI: 10.1053/j.gastro.2019.12.051</identifier><identifier>PMID: 31972237</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Antineoplastic Combined Chemotherapy Protocols - pharmacology ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Clinical Trials as Topic ; Colorectal Neoplasms - drug therapy ; Colorectal Neoplasms - genetics ; Drug Resistance, Neoplasm - drug effects ; Drug Resistance, Neoplasm - genetics ; Gain of Function Mutation ; GTP Phosphohydrolases - antagonists & inhibitors ; GTP Phosphohydrolases - genetics ; Humans ; MAP Kinase Signaling System - drug effects ; MAP Kinase Signaling System - genetics ; Membrane Proteins - antagonists & inhibitors ; Membrane Proteins - genetics ; Microsatellite Instability ; Mutation, Missense ; Precision Medicine - methods ; Protein Kinase Inhibitors - pharmacology ; Protein Kinase Inhibitors - therapeutic use ; Proto-Oncogene Proteins p21(ras) - antagonists & inhibitors ; Proto-Oncogene Proteins p21(ras) - genetics ; Treatment Outcome</subject><ispartof>Gastroenterology (New York, N.Y. 1943), 2020-03, Vol.158 (4), p.806-811</ispartof><rights>2020 AGA Institute</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-6380d66bdf994be1729a9c53e59f3c56ea949e6fe43766f399b1c6f9447835003</citedby><cites>FETCH-LOGICAL-c408t-6380d66bdf994be1729a9c53e59f3c56ea949e6fe43766f399b1c6f9447835003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1053/j.gastro.2019.12.051$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31972237$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dienstmann, Rodrigo</creatorcontrib><creatorcontrib>Connor, Kate</creatorcontrib><creatorcontrib>Byrne, Annette T.</creatorcontrib><creatorcontrib>Fridman, W.H.</creatorcontrib><creatorcontrib>Lambrechts, D.</creatorcontrib><creatorcontrib>Sadanandam, A.</creatorcontrib><creatorcontrib>Trusolino, L.</creatorcontrib><creatorcontrib>Prehn, J.H.M.</creatorcontrib><creatorcontrib>Tabernero, J.</creatorcontrib><creatorcontrib>Kolch, W.</creatorcontrib><creatorcontrib>COLOSSUS Consortium</creatorcontrib><title>Precision Therapy in RAS Mutant Colorectal Cancer</title><title>Gastroenterology (New York, N.Y. 1943)</title><addtitle>Gastroenterology</addtitle><subject>Antineoplastic Combined Chemotherapy Protocols - pharmacology</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Clinical Trials as Topic</subject><subject>Colorectal Neoplasms - drug therapy</subject><subject>Colorectal Neoplasms - genetics</subject><subject>Drug Resistance, Neoplasm - drug effects</subject><subject>Drug Resistance, Neoplasm - genetics</subject><subject>Gain of Function Mutation</subject><subject>GTP Phosphohydrolases - antagonists & inhibitors</subject><subject>GTP Phosphohydrolases - genetics</subject><subject>Humans</subject><subject>MAP Kinase Signaling System - drug effects</subject><subject>MAP Kinase Signaling System - genetics</subject><subject>Membrane Proteins - antagonists & inhibitors</subject><subject>Membrane Proteins - genetics</subject><subject>Microsatellite Instability</subject><subject>Mutation, Missense</subject><subject>Precision Medicine - methods</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Protein Kinase Inhibitors - therapeutic use</subject><subject>Proto-Oncogene Proteins p21(ras) - antagonists & inhibitors</subject><subject>Proto-Oncogene Proteins p21(ras) - genetics</subject><subject>Treatment Outcome</subject><issn>0016-5085</issn><issn>1528-0012</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLw0AUhQdRbK3-A5Es3STOO5mNIMUXVBSt62EyudEpaabOJEL_vSmpLl2dzXfu4X4InROcESzY1Sr7MLELPqOYqIzQDAtygKZE0CLFmNBDNB1CpgIXYoJOYlxhjBUryDGaMKJySlk-ReQlgHXR-TZZfkIwm23i2uT15i156jvTdsncN35AOtMkc9NaCKfoqDZNhLN9ztD73e1y_pAunu8f5zeL1HJcdKlkBa6kLKtaKV4CyakyygoGQtXMCglGcQWyBs5yKWumVEmsrBXnecEExmyGLse7m-C_eoidXrtooWlMC76PmjLOaS4ULgaUj6gNPsYAtd4EtzZhqwnWO1l6pUdZeidLE6oHWUPtYr_Ql2uo_kq_dgbgegRg-PPbQdDROhgkVG6nRFfe_b_wA5T7epA</recordid><startdate>202003</startdate><enddate>202003</enddate><creator>Dienstmann, Rodrigo</creator><creator>Connor, Kate</creator><creator>Byrne, Annette T.</creator><creator>Fridman, W.H.</creator><creator>Lambrechts, D.</creator><creator>Sadanandam, A.</creator><creator>Trusolino, L.</creator><creator>Prehn, J.H.M.</creator><creator>Tabernero, J.</creator><creator>Kolch, W.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202003</creationdate><title>Precision Therapy in RAS Mutant Colorectal Cancer</title><author>Dienstmann, Rodrigo ; Connor, Kate ; Byrne, Annette T. ; Fridman, W.H. ; Lambrechts, D. ; Sadanandam, A. ; Trusolino, L. ; Prehn, J.H.M. ; Tabernero, J. ; Kolch, W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-6380d66bdf994be1729a9c53e59f3c56ea949e6fe43766f399b1c6f9447835003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antineoplastic Combined Chemotherapy Protocols - pharmacology</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Clinical Trials as Topic</topic><topic>Colorectal Neoplasms - drug therapy</topic><topic>Colorectal Neoplasms - genetics</topic><topic>Drug Resistance, Neoplasm - drug effects</topic><topic>Drug Resistance, Neoplasm - genetics</topic><topic>Gain of Function Mutation</topic><topic>GTP Phosphohydrolases - antagonists & inhibitors</topic><topic>GTP Phosphohydrolases - genetics</topic><topic>Humans</topic><topic>MAP Kinase Signaling System - drug effects</topic><topic>MAP Kinase Signaling System - genetics</topic><topic>Membrane Proteins - antagonists & inhibitors</topic><topic>Membrane Proteins - genetics</topic><topic>Microsatellite Instability</topic><topic>Mutation, Missense</topic><topic>Precision Medicine - methods</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Protein Kinase Inhibitors - therapeutic use</topic><topic>Proto-Oncogene Proteins p21(ras) - antagonists & inhibitors</topic><topic>Proto-Oncogene Proteins p21(ras) - genetics</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dienstmann, Rodrigo</creatorcontrib><creatorcontrib>Connor, Kate</creatorcontrib><creatorcontrib>Byrne, Annette T.</creatorcontrib><creatorcontrib>Fridman, W.H.</creatorcontrib><creatorcontrib>Lambrechts, D.</creatorcontrib><creatorcontrib>Sadanandam, A.</creatorcontrib><creatorcontrib>Trusolino, L.</creatorcontrib><creatorcontrib>Prehn, J.H.M.</creatorcontrib><creatorcontrib>Tabernero, J.</creatorcontrib><creatorcontrib>Kolch, W.</creatorcontrib><creatorcontrib>COLOSSUS Consortium</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gastroenterology (New York, N.Y. 1943)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dienstmann, Rodrigo</au><au>Connor, Kate</au><au>Byrne, Annette T.</au><au>Fridman, W.H.</au><au>Lambrechts, D.</au><au>Sadanandam, A.</au><au>Trusolino, L.</au><au>Prehn, J.H.M.</au><au>Tabernero, J.</au><au>Kolch, W.</au><aucorp>COLOSSUS Consortium</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Precision Therapy in RAS Mutant Colorectal Cancer</atitle><jtitle>Gastroenterology (New York, N.Y. 1943)</jtitle><addtitle>Gastroenterology</addtitle><date>2020-03</date><risdate>2020</risdate><volume>158</volume><issue>4</issue><spage>806</spage><epage>811</epage><pages>806-811</pages><issn>0016-5085</issn><eissn>1528-0012</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31972237</pmid><doi>10.1053/j.gastro.2019.12.051</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0016-5085 |
| ispartof | Gastroenterology (New York, N.Y. 1943), 2020-03, Vol.158 (4), p.806-811 |
| issn | 0016-5085 1528-0012 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2344275908 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present); Alma/SFX Local Collection |
| subjects | Antineoplastic Combined Chemotherapy Protocols - pharmacology Antineoplastic Combined Chemotherapy Protocols - therapeutic use Clinical Trials as Topic Colorectal Neoplasms - drug therapy Colorectal Neoplasms - genetics Drug Resistance, Neoplasm - drug effects Drug Resistance, Neoplasm - genetics Gain of Function Mutation GTP Phosphohydrolases - antagonists & inhibitors GTP Phosphohydrolases - genetics Humans MAP Kinase Signaling System - drug effects MAP Kinase Signaling System - genetics Membrane Proteins - antagonists & inhibitors Membrane Proteins - genetics Microsatellite Instability Mutation, Missense Precision Medicine - methods Protein Kinase Inhibitors - pharmacology Protein Kinase Inhibitors - therapeutic use Proto-Oncogene Proteins p21(ras) - antagonists & inhibitors Proto-Oncogene Proteins p21(ras) - genetics Treatment Outcome |
| title | Precision Therapy in RAS Mutant Colorectal Cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T11%3A48%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Precision%20Therapy%20in%20RAS%20Mutant%20Colorectal%20Cancer&rft.jtitle=Gastroenterology%20(New%20York,%20N.Y.%201943)&rft.au=Dienstmann,%20Rodrigo&rft.aucorp=COLOSSUS%20Consortium&rft.date=2020-03&rft.volume=158&rft.issue=4&rft.spage=806&rft.epage=811&rft.pages=806-811&rft.issn=0016-5085&rft.eissn=1528-0012&rft_id=info:doi/10.1053/j.gastro.2019.12.051&rft_dat=%3Cproquest_cross%3E2344275908%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2344275908&rft_id=info:pmid/31972237&rft_els_id=S0016508520301141&rfr_iscdi=true |